| Literature DB >> 30318155 |
Yuki Kagoya1, Hiroshi Saijo1, Yukiko Matsunaga1, Tingxi Guo2, Kayoko Saso1, Mark Anczurowski2, Chung-Hsi Wang2, Kenji Sugata1, Kenji Murata1, Marcus O Butler3, Cheryl H Arrowsmith4, Naoto Hirano5.
Abstract
Forkhead box transcription factor 3 (FOXP3) plays a pivotal role in the suppressive function of regulatory T cells. In addition to mRNA levels, FOXP3 activity can also be controlled by posttranslational mechanisms, which have not been studied in a comprehensive manner. Through extensive screening using selective inhibitors, we demonstrate that the inhibition of type I protein arginine methytransferases (PRMTs) attenuates the suppressive functions of regulatory T cells. FOXP3 undergoes methylation on arginine residues at positions 48 and 51 by interacting with protein arginine methyltransferase 1 (PRMT1). The inhibition of arginine methylation confers gene expression profiles representing type I helper T cells to FOXP3+ T cells, which results in attenuated suppressive activity. A methylation-defective mutant of FOXP3 displays less potent activity to suppress xenogeneic graft-versus-host disease in vivo. These results elucidate an important role of arginine methylation to enhance FOXP3 functions and are potentially applicable to modulate regulatory T cell functions.Entities:
Keywords: Arginine methylation; FOXP3; Graft-versus-host disease; PRMT1; Posttranslational modification; Regulatory T cells
Mesh:
Substances:
Year: 2018 PMID: 30318155 DOI: 10.1016/j.jaut.2018.09.011
Source DB: PubMed Journal: J Autoimmun ISSN: 0896-8411 Impact factor: 7.094